Top Markets
Coin of the day
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Rang in Aktien #25519
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Aktienkurs
$9.81
Zuletzt synchronisiert: 2025-03-18
Marktkapitalisierung
$48.68M
Veränderung (1 Tag)
1.55%
Veränderung (1 Jahr)
0.00%
Land
US
Handel AlloVir, Inc. (ALVR)

Kategorie

EPS für AlloVir, Inc. (ALVR)
EPS zum June 2026 TTM: $-1.71
Laut den aktuellen Finanzberichten und dem Aktienkurs von AlloVir, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $-1.71. Am Ende des Jahres 2023 betrug das EPS $-42.09 ein Rückgang im Vergleich zu dem EPS von 2022, das $-50.60 betrug.
EPS-Verlauf von AlloVir, Inc. von 2018 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-1.71 -85.42%
2024 $-11.73 -72.13%
2023 $-42.09 -16.82%
2022 $-50.60 -19.71%
2021 $-63.02 5.79%
2020 $-59.57 354.39%
2019 $-13.11 71,150.00%
2018 $-0.02 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -1,112.87%
US
$27.74 -1,722.22%
NL
$2.98 -274.27%
AU
- -
CH
$-7.98 366.67%
US